Related Experiment Video
Updated: Feb 21, 2026
08:49
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
9.3K
The Serotonin Receptor Subtype 5b Specifically Interacts with Serotonin Receptor Subtype 1A
Sabine Niebert1, Gijsbert J van Belle2, Steffen Vogelgesang3,4
1Department of Maxillofacial Surgery, University Medical CenterGöttingen, Germany.
Frontiers in Molecular Neuroscience
|October 7, 2017
Summary
Serotonin 5-HT5B receptors are found in endosomes, not on cell surfaces. These receptors interact with 5-HT1A receptors, reducing their surface expression and potentially regulating serotonin signaling.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Serotonin (5-HT) receptor subtype 5b (5-ht5B) dysregulation was previously noted in a Rett syndrome mouse model.
- The 5-ht5B receptor remains understudied, necessitating further characterization.
Purpose of the Study:
- To investigate the subcellular localization and functional relevance of the 5-ht5B receptor.
- To elucidate the interaction between 5-ht5B and other serotonin receptors, specifically 5-HT1A.
Main Methods:
- Cellular and molecular biology techniques to analyze receptor expression and localization.
- Biochemical assays to study receptor interactions and trafficking.
- Analysis of N-terminal glycosylation's role in subcellular localization.
Main Results:
- 5-ht5B receptors exhibit unique endosomal localization, unlike typical cell surface receptors.
- N-terminal glycosylation influences the endosomal trafficking of 5-ht5B.
- 5-ht5B receptors specifically interact with 5-HT1A receptors within endosomes.
- This interaction leads to reduced surface expression of 5-HT1A receptors, mediated by transmembrane domain interactions.
Conclusions:
- The unusual endosomal localization of 5-ht5B is partly determined by its glycosylation pattern.
- 5-ht5B can modulate 5-HT1A receptor activity by retaining them in endosomes, thus affecting serotonin signaling pathways.
More Related Videos
Related Concept Videos
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.1K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K
01:21G-protein Coupled Receptors
132.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.4K
01:23Antidepressant Drugs: MAOIs and Other Agents
991
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
991
01:25Dose-Response Relationship: Selectivity and Specificity
10.0K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.0K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.8K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.8K